Delivery Order SPE2DB20D2104-SPE2DB26FMAPY
Award Date 10/21/25
Potential Completion Date 10/22/25
Potential Value $9.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $10,676.55 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Rexulti 1 mg on September 5, 2025, with a completion date of September 8, 2025. This competitively awarded, firm fixed-price contract is non-set-aside and represents a child delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where the vendor maintains its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $28,937.85 to AmerisourceBergen Drug Corp for 30 tablets of Rexulti 3 mg on September 16, 2025, with completion targeted for September 17, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and represents a single transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The pharmaceutical product will be delivered to the...
- The Defense Logistics Agency awarded a delivery order valued at $3,043.89 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count packages) on July 14, 2025, with completion scheduled for July 15, 2025. This firm fixed price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The work...
- The Defense Logistics Agency awarded a delivery order valued at $10,036.57 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed-price contract type. The award was made on August 26, 2025, with an ultimate completion date of August 27, 2025, and represents a non-competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the delivery order from its Conshohocken facility. This...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order valued at $31,550.03 to AmerisourceBergen Drug Corp for the supply of Rexulti 0.5 mg tablets (30-count) under contract number 4569070004. This non-competitive delivery order, awarded on August 12, 2025, with an ultimate completion date of August 13, 2025, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical...
- The Defense Logistics Agency awarded a delivery order valued at $2,417.22 to AmerisourceBergen Drug Corp for Rexulti 2 mg tablets (30-count package) on September 25, 2025, with an ultimate completion date of September 26, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,407.85 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count) on September 17, 2025, with an ultimate completion date of September 18, 2025. This firm fixed-price delivery order represents a non-competitive award issued under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global pharmaceutical support vehicle that enables comprehensive...
- The Defense Logistics Agency awarded a delivery order valued at $17,806.56 to AmerisourceBergen Drug Corp for the supply of Rexulti 1 mg tablets (30-count units) on August 25, 2025, with an ultimate completion date of August 26, 2025. This firm fixed-price delivery order represents a non-competitive award and serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $10,096.14 to AmerisourceBergen Drug Corp for the supply of Rexulti 3 mg tablets (30-count packages) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,122.46 to AmerisourceBergen Drug Corp for the supply of Rexulti 2 mg tablets (30-count units) under a firm fixed price contract. This non-set-aside award was issued on October 17, 2025, with an ultimate completion date of October 20, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is the performer of record for this delivery order. This award represents a child contract action under the company's larger...